MedPath

ACTAEA RACEMOSA

ACTAEA RACEMOSA

Discontinued
DIN Number

02233077

Drug Class

Human

Market Date

Apr 6, 1998

Company
HC

seroyal international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233077
AIG Number0107242003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormGranules ,  Liquid ,  Tablet ,  Globules ,  Drops ,  Pellet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

CIMICIFUGA RACEMOSAActive
Strength: 1 X
Monograph: CIMICIFUGA RACEMOSA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.